600489:SSEZhongjin Gold Corp., Ltd. Class A Analysis
Data as of 2026-05-29 - not real-time
CN¥22.42
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Zhongjin Gold is trading at CNY 22.42, well below its 20‑day SMA of 24.98 and 50‑day SMA of 25.95, signaling short‑term weakness. The RSI sits at 34, hinting at modest oversold pressure, while a bearish MACD (line –1.07 vs signal –0.89) and decreasing volume reinforce the downside bias. However, the stock’s volatility is high at 43% over the past 30 days, yet its beta is extremely low (≈0.04), suggesting limited correlation with broader market moves.
Fundamentally, the company posted a 52% revenue surge, maintains a solid ROE of 20.8% and ROA of 9.9%, and carries a moderate debt‑to‑equity of 53% backed by CNY 15.3 bn of cash. The DCF‑derived fair value of CNY 16.25 is far below the current price, indicating the market is pricing in a premium, while the dividend yield of 1.73% with a 30% payout appears sustainable given strong operating cash flow.
Fundamentally, the company posted a 52% revenue surge, maintains a solid ROE of 20.8% and ROA of 9.9%, and carries a moderate debt‑to‑equity of 53% backed by CNY 15.3 bn of cash. The DCF‑derived fair value of CNY 16.25 is far below the current price, indicating the market is pricing in a premium, while the dividend yield of 1.73% with a 30% payout appears sustainable given strong operating cash flow.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Price below key moving averages and near support
- Bearish MACD and decreasing volume
- Current price exceeds DCF fair value
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Strong revenue growth and solid profitability metrics
- Sustainable dividend yield with comfortable payout ratio
- Moderate debt level offset by ample cash reserves
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust ROE and cash generation supporting long‑term value
- Exposure to gold fundamentals which can appreciate over time
- Potential price correction toward DCF fair value offering upside
Key Metrics & Analysis
Financial Health
Revenue Growth52.00%
Profit Margin7.23%
P/E Ratio17.2
ROE20.85%
ROA9.94%
Debt/Equity53.26
P/B Ratio3.3
Op. Cash FlowCN¥8.2B
Free Cash FlowCN¥2.3B
Technical Analysis
TrendNeutral
RSI34.3
SupportCN¥21.92
ResistanceCN¥28.48
MA 20CN¥24.98
MA 50CN¥25.95
MA 200CN¥23.89
MACDBearish
VolumeDecreasing
Fear & Greed Index93.09
Valuation
Fair ValueCN¥16.25
GradeOvervalued
TypeGrowth
Dividend Yield1.73%
Risk Assessment
Beta0.04
Volatility43.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.